SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Name | miRBASE accession |
---|---|
hsa-miR-137
|
MIMAT0000429 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_155484103 | 2.85 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr2_+_42275153 | 2.71 |
ENST00000294964.5
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
chr19_+_589893 | 2.01 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
chr7_+_1570322 | 1.93 |
ENST00000343242.4
|
MAFK
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K |
chr1_-_89591749 | 1.90 |
ENST00000370466.3
|
GBP2
|
guanylate binding protein 2, interferon-inducible |
chr8_+_142402089 | 1.81 |
ENST00000521578.1
ENST00000520105.1 ENST00000523147.1 |
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3 |
chr20_-_5591626 | 1.78 |
ENST00000379019.4
|
GPCPD1
|
glycerophosphocholine phosphodiesterase GDE1 homolog (S. cerevisiae) |
chr16_+_1203194 | 1.70 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr16_+_2076869 | 1.67 |
ENST00000424542.2
ENST00000432365.2 |
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
chr11_+_2920951 | 1.59 |
ENST00000347936.2
|
SLC22A18
|
solute carrier family 22, member 18 |
chr19_+_47778119 | 1.58 |
ENST00000552360.2
|
PRR24
|
proline rich 24 |
chr10_+_112257596 | 1.50 |
ENST00000369583.3
|
DUSP5
|
dual specificity phosphatase 5 |
chr19_+_35521572 | 1.42 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr3_+_183948161 | 1.41 |
ENST00000426955.2
|
VWA5B2
|
von Willebrand factor A domain containing 5B2 |
chr22_+_48972118 | 1.40 |
ENST00000358295.5
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
chr8_-_66754172 | 1.40 |
ENST00000401827.3
|
PDE7A
|
phosphodiesterase 7A |
chr2_+_198365122 | 1.35 |
ENST00000604458.1
|
HSPE1-MOB4
|
HSPE1-MOB4 readthrough |
chr13_-_110438914 | 1.34 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chr20_-_32262165 | 1.31 |
ENST00000606690.1
ENST00000246190.6 ENST00000439478.1 ENST00000375238.4 |
NECAB3
|
N-terminal EF-hand calcium binding protein 3 |
chr19_+_8455077 | 1.30 |
ENST00000328024.6
|
RAB11B
|
RAB11B, member RAS oncogene family |
chr1_-_204165610 | 1.22 |
ENST00000367194.4
|
KISS1
|
KiSS-1 metastasis-suppressor |
chr12_+_58148842 | 1.20 |
ENST00000266643.5
|
MARCH9
|
membrane-associated ring finger (C3HC4) 9 |
chr19_-_8642289 | 1.19 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
chr3_+_127391769 | 1.17 |
ENST00000393363.3
ENST00000232744.8 ENST00000453791.2 |
ABTB1
|
ankyrin repeat and BTB (POZ) domain containing 1 |
chr3_-_114790179 | 1.15 |
ENST00000462705.1
|
ZBTB20
|
zinc finger and BTB domain containing 20 |
chr11_-_65640325 | 1.11 |
ENST00000307998.6
|
EFEMP2
|
EGF containing fibulin-like extracellular matrix protein 2 |
chr7_-_139876812 | 1.05 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr7_-_19157248 | 1.05 |
ENST00000242261.5
|
TWIST1
|
twist family bHLH transcription factor 1 |
chr7_+_192969 | 1.04 |
ENST00000313766.5
|
FAM20C
|
family with sequence similarity 20, member C |
chr5_-_59189545 | 1.03 |
ENST00000340635.6
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific |
chr1_+_895930 | 1.02 |
ENST00000338591.3
|
KLHL17
|
kelch-like family member 17 |
chr19_+_4007644 | 1.01 |
ENST00000262971.2
|
PIAS4
|
protein inhibitor of activated STAT, 4 |
chr9_-_130693048 | 1.00 |
ENST00000388747.4
|
PIP5KL1
|
phosphatidylinositol-4-phosphate 5-kinase-like 1 |
chr19_+_16435625 | 0.99 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr11_-_1593150 | 0.99 |
ENST00000397374.3
|
DUSP8
|
dual specificity phosphatase 8 |
chr12_-_54779511 | 0.99 |
ENST00000551109.1
ENST00000546970.1 |
ZNF385A
|
zinc finger protein 385A |
chr12_+_57916466 | 0.98 |
ENST00000355673.3
|
MBD6
|
methyl-CpG binding domain protein 6 |
chr11_-_117747607 | 0.97 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr10_-_71892555 | 0.96 |
ENST00000307864.1
|
AIFM2
|
apoptosis-inducing factor, mitochondrion-associated, 2 |
chr19_+_35759824 | 0.96 |
ENST00000343550.5
|
USF2
|
upstream transcription factor 2, c-fos interacting |
chr19_-_17445613 | 0.94 |
ENST00000159087.4
|
ANO8
|
anoctamin 8 |
chr21_-_44846999 | 0.92 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
chr19_-_46476791 | 0.92 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
chr8_-_144623595 | 0.91 |
ENST00000262577.5
|
ZC3H3
|
zinc finger CCCH-type containing 3 |
chr7_+_155250824 | 0.91 |
ENST00000297375.4
|
EN2
|
engrailed homeobox 2 |
chr19_+_1286097 | 0.89 |
ENST00000215368.2
|
EFNA2
|
ephrin-A2 |
chr5_-_172198190 | 0.88 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr19_-_45663408 | 0.88 |
ENST00000317951.4
|
NKPD1
|
NTPase, KAP family P-loop domain containing 1 |
chr11_-_45687128 | 0.87 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr12_+_54402790 | 0.87 |
ENST00000040584.4
|
HOXC8
|
homeobox C8 |
chr12_-_98897617 | 0.86 |
ENST00000501499.1
|
RP11-181C3.1
|
Uncharacterized protein |
chr2_+_207308220 | 0.86 |
ENST00000264377.3
|
ADAM23
|
ADAM metallopeptidase domain 23 |
chr1_-_240775447 | 0.84 |
ENST00000318160.4
|
GREM2
|
gremlin 2, DAN family BMP antagonist |
chr3_+_85008089 | 0.84 |
ENST00000383699.3
|
CADM2
|
cell adhesion molecule 2 |
chr14_+_93389425 | 0.84 |
ENST00000216492.5
ENST00000334654.4 |
CHGA
|
chromogranin A (parathyroid secretory protein 1) |
chr12_+_51985001 | 0.84 |
ENST00000354534.6
|
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit |
chr12_+_52203789 | 0.82 |
ENST00000599343.1
|
AC068987.1
|
HCG1997999; cDNA FLJ33996 fis, clone DFNES2008881 |
chr15_+_44092784 | 0.82 |
ENST00000458412.1
|
HYPK
|
huntingtin interacting protein K |
chr16_-_29910365 | 0.81 |
ENST00000346932.5
ENST00000350527.3 ENST00000537485.1 ENST00000568380.1 |
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
chr11_-_117667806 | 0.81 |
ENST00000527706.1
ENST00000321322.6 |
DSCAML1
|
Down syndrome cell adhesion molecule like 1 |
chr2_-_182545603 | 0.80 |
ENST00000295108.3
|
NEUROD1
|
neuronal differentiation 1 |
chr20_+_35974532 | 0.80 |
ENST00000373578.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
chr16_+_4364762 | 0.80 |
ENST00000262366.3
|
GLIS2
|
GLIS family zinc finger 2 |
chr2_+_85981008 | 0.78 |
ENST00000306279.3
|
ATOH8
|
atonal homolog 8 (Drosophila) |
chr7_-_100287071 | 0.76 |
ENST00000275732.5
|
GIGYF1
|
GRB10 interacting GYF protein 1 |
chr16_-_31021921 | 0.74 |
ENST00000215095.5
|
STX1B
|
syntaxin 1B |
chr17_+_53342311 | 0.73 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
chr2_+_155554797 | 0.72 |
ENST00000295101.2
|
KCNJ3
|
potassium inwardly-rectifying channel, subfamily J, member 3 |
chr12_+_54447637 | 0.72 |
ENST00000609810.1
ENST00000430889.2 |
HOXC4
HOXC4
|
homeobox C4 Homeobox protein Hox-C4 |
chr10_-_94003003 | 0.71 |
ENST00000412050.4
|
CPEB3
|
cytoplasmic polyadenylation element binding protein 3 |
chr4_-_105416039 | 0.70 |
ENST00000394767.2
|
CXXC4
|
CXXC finger protein 4 |
chr19_+_797392 | 0.70 |
ENST00000350092.4
ENST00000349038.4 ENST00000586481.1 ENST00000585535.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
chr11_-_62380199 | 0.69 |
ENST00000419857.1
ENST00000394773.2 |
EML3
|
echinoderm microtubule associated protein like 3 |
chr20_+_42086525 | 0.69 |
ENST00000244020.3
|
SRSF6
|
serine/arginine-rich splicing factor 6 |
chr1_+_155051305 | 0.68 |
ENST00000368408.3
|
EFNA3
|
ephrin-A3 |
chr4_-_23891693 | 0.68 |
ENST00000264867.2
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
chr10_-_35930219 | 0.68 |
ENST00000374694.1
|
FZD8
|
frizzled family receptor 8 |
chr9_+_136325089 | 0.68 |
ENST00000291722.7
ENST00000316948.4 ENST00000540581.1 |
CACFD1
|
calcium channel flower domain containing 1 |
chr22_+_50609150 | 0.68 |
ENST00000159647.5
ENST00000395842.2 |
PANX2
|
pannexin 2 |
chr17_-_7832753 | 0.68 |
ENST00000303790.2
|
KCNAB3
|
potassium voltage-gated channel, shaker-related subfamily, beta member 3 |
chr15_-_61521495 | 0.68 |
ENST00000335670.6
|
RORA
|
RAR-related orphan receptor A |
chr6_-_3457256 | 0.67 |
ENST00000436008.2
|
SLC22A23
|
solute carrier family 22, member 23 |
chr7_+_128864848 | 0.66 |
ENST00000325006.3
ENST00000446544.2 |
AHCYL2
|
adenosylhomocysteinase-like 2 |
chr14_-_24911971 | 0.65 |
ENST00000555365.1
ENST00000399395.3 |
SDR39U1
|
short chain dehydrogenase/reductase family 39U, member 1 |
chr11_+_65082289 | 0.65 |
ENST00000279249.2
|
CDC42EP2
|
CDC42 effector protein (Rho GTPase binding) 2 |
chr14_+_53019822 | 0.64 |
ENST00000321662.6
|
GPR137C
|
G protein-coupled receptor 137C |
chr12_+_113659234 | 0.64 |
ENST00000551096.1
ENST00000551099.1 ENST00000335509.6 ENST00000552897.1 ENST00000550785.1 ENST00000549279.1 |
TPCN1
|
two pore segment channel 1 |
chr2_+_113033164 | 0.64 |
ENST00000409871.1
ENST00000343936.4 |
ZC3H6
|
zinc finger CCCH-type containing 6 |
chr19_+_51815102 | 0.64 |
ENST00000270642.8
|
IGLON5
|
IgLON family member 5 |
chr12_+_122516626 | 0.63 |
ENST00000319080.7
|
MLXIP
|
MLX interacting protein |
chr7_+_128784712 | 0.63 |
ENST00000289407.4
|
TSPAN33
|
tetraspanin 33 |
chr12_-_49504655 | 0.62 |
ENST00000551782.1
ENST00000267102.8 |
LMBR1L
|
limb development membrane protein 1-like |
chr12_-_120806960 | 0.62 |
ENST00000257552.2
|
MSI1
|
musashi RNA-binding protein 1 |
chr4_-_90229142 | 0.62 |
ENST00000609438.1
|
GPRIN3
|
GPRIN family member 3 |
chr18_-_12884150 | 0.61 |
ENST00000591115.1
ENST00000309660.5 |
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2 |
chr5_-_133968529 | 0.60 |
ENST00000402673.2
|
SAR1B
|
SAR1 homolog B (S. cerevisiae) |
chr12_+_2162447 | 0.60 |
ENST00000335762.5
ENST00000399655.1 |
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
chr6_+_70576457 | 0.60 |
ENST00000322773.4
|
COL19A1
|
collagen, type XIX, alpha 1 |
chr19_-_409134 | 0.59 |
ENST00000332235.6
|
C2CD4C
|
C2 calcium-dependent domain containing 4C |
chr12_+_57482665 | 0.59 |
ENST00000300131.3
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2) |
chr19_+_1205740 | 0.58 |
ENST00000326873.7
|
STK11
|
serine/threonine kinase 11 |
chr4_-_1242764 | 0.58 |
ENST00000514210.1
ENST00000382952.3 ENST00000290921.6 |
CTBP1
|
C-terminal binding protein 1 |
chr5_-_22853429 | 0.57 |
ENST00000504376.2
|
CDH12
|
cadherin 12, type 2 (N-cadherin 2) |
chr11_-_70507901 | 0.57 |
ENST00000449833.2
ENST00000357171.3 ENST00000449116.2 |
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
chr2_-_101034070 | 0.57 |
ENST00000264249.3
|
CHST10
|
carbohydrate sulfotransferase 10 |
chr1_-_153919128 | 0.56 |
ENST00000361217.4
|
DENND4B
|
DENN/MADD domain containing 4B |
chr9_+_12775011 | 0.56 |
ENST00000319264.3
|
LURAP1L
|
leucine rich adaptor protein 1-like |
chr8_-_29208183 | 0.55 |
ENST00000240100.2
|
DUSP4
|
dual specificity phosphatase 4 |
chr4_+_129730779 | 0.55 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
chr19_+_45596218 | 0.55 |
ENST00000421905.1
ENST00000221462.4 |
PPP1R37
|
protein phosphatase 1, regulatory subunit 37 |
chr16_+_28303804 | 0.55 |
ENST00000341901.4
|
SBK1
|
SH3 domain binding kinase 1 |
chr18_-_51751132 | 0.55 |
ENST00000256429.3
|
MBD2
|
methyl-CpG binding domain protein 2 |
chr17_+_39845134 | 0.54 |
ENST00000591776.1
ENST00000469257.1 |
EIF1
|
eukaryotic translation initiation factor 1 |
chr6_+_17281573 | 0.54 |
ENST00000379052.5
|
RBM24
|
RNA binding motif protein 24 |
chr12_+_20522179 | 0.53 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
chr16_+_67880574 | 0.53 |
ENST00000219169.4
|
NUTF2
|
nuclear transport factor 2 |
chr19_-_1848451 | 0.53 |
ENST00000170168.4
|
REXO1
|
REX1, RNA exonuclease 1 homolog (S. cerevisiae) |
chr13_-_29292956 | 0.52 |
ENST00000266943.6
|
SLC46A3
|
solute carrier family 46, member 3 |
chr19_-_4182530 | 0.52 |
ENST00000601571.1
ENST00000601488.1 ENST00000305232.6 ENST00000381935.3 ENST00000337491.2 |
SIRT6
|
sirtuin 6 |
chr6_-_91006461 | 0.52 |
ENST00000257749.4
ENST00000343122.3 ENST00000406998.2 ENST00000453877.1 |
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr4_+_150999418 | 0.52 |
ENST00000296550.7
|
DCLK2
|
doublecortin-like kinase 2 |
chr12_+_49761224 | 0.51 |
ENST00000553127.1
ENST00000321898.6 |
SPATS2
|
spermatogenesis associated, serine-rich 2 |
chr6_-_33756867 | 0.51 |
ENST00000293760.5
|
LEMD2
|
LEM domain containing 2 |
chr20_+_61427797 | 0.51 |
ENST00000370487.3
|
MRGBP
|
MRG/MORF4L binding protein |
chr11_-_63684316 | 0.50 |
ENST00000301459.4
|
RCOR2
|
REST corepressor 2 |
chr2_+_5832799 | 0.50 |
ENST00000322002.3
|
SOX11
|
SRY (sex determining region Y)-box 11 |
chr14_-_99737565 | 0.50 |
ENST00000357195.3
|
BCL11B
|
B-cell CLL/lymphoma 11B (zinc finger protein) |
chr2_-_40679186 | 0.49 |
ENST00000406785.2
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1 |
chr14_+_74111578 | 0.49 |
ENST00000554113.1
ENST00000555631.2 ENST00000553645.2 ENST00000311089.3 ENST00000555919.3 ENST00000554339.1 ENST00000554871.1 |
DNAL1
|
dynein, axonemal, light chain 1 |
chr7_+_76090993 | 0.49 |
ENST00000425780.1
ENST00000456590.1 ENST00000451769.1 ENST00000324432.5 ENST00000307569.8 ENST00000457529.1 ENST00000446600.1 ENST00000413936.2 ENST00000423646.1 ENST00000438930.1 ENST00000430490.2 |
DTX2
|
deltex homolog 2 (Drosophila) |
chr20_+_30555805 | 0.49 |
ENST00000562532.2
|
XKR7
|
XK, Kell blood group complex subunit-related family, member 7 |
chr11_-_66336060 | 0.49 |
ENST00000310325.5
|
CTSF
|
cathepsin F |
chr3_+_49591881 | 0.49 |
ENST00000296452.4
|
BSN
|
bassoon presynaptic cytomatrix protein |
chr7_-_117513540 | 0.48 |
ENST00000160373.3
|
CTTNBP2
|
cortactin binding protein 2 |
chr8_+_21946681 | 0.48 |
ENST00000289921.7
|
FAM160B2
|
family with sequence similarity 160, member B2 |
chr9_-_93405352 | 0.48 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
chr8_+_12803176 | 0.48 |
ENST00000524591.2
|
KIAA1456
|
KIAA1456 |
chr7_+_119913688 | 0.47 |
ENST00000331113.4
|
KCND2
|
potassium voltage-gated channel, Shal-related subfamily, member 2 |
chr11_+_74951948 | 0.47 |
ENST00000562197.2
|
TPBGL
|
trophoblast glycoprotein-like |
chr1_+_61547894 | 0.47 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr7_+_28452130 | 0.46 |
ENST00000357727.2
|
CREB5
|
cAMP responsive element binding protein 5 |
chr4_-_142053952 | 0.46 |
ENST00000515673.2
|
RNF150
|
ring finger protein 150 |
chr8_+_106330920 | 0.46 |
ENST00000407775.2
|
ZFPM2
|
zinc finger protein, FOG family member 2 |
chr1_+_2985760 | 0.45 |
ENST00000378391.2
ENST00000514189.1 ENST00000270722.5 |
PRDM16
|
PR domain containing 16 |
chr17_-_7137857 | 0.45 |
ENST00000005340.5
|
DVL2
|
dishevelled segment polarity protein 2 |
chr12_+_123319973 | 0.45 |
ENST00000253083.4
|
HIP1R
|
huntingtin interacting protein 1 related |
chr16_-_2264779 | 0.45 |
ENST00000333503.7
|
PGP
|
phosphoglycolate phosphatase |
chr5_-_147162078 | 0.45 |
ENST00000507386.1
|
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr2_-_43453734 | 0.45 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
chr10_-_64576105 | 0.44 |
ENST00000242480.3
ENST00000411732.1 |
EGR2
|
early growth response 2 |
chr1_-_72748417 | 0.44 |
ENST00000357731.5
|
NEGR1
|
neuronal growth regulator 1 |
chr1_-_242687676 | 0.44 |
ENST00000536534.2
|
PLD5
|
phospholipase D family, member 5 |
chr11_+_109292846 | 0.44 |
ENST00000327419.6
|
C11orf87
|
chromosome 11 open reading frame 87 |
chr22_+_39966758 | 0.44 |
ENST00000407673.1
ENST00000401624.1 ENST00000404898.1 ENST00000402142.3 ENST00000336649.4 ENST00000400164.3 |
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit |
chr12_-_42538657 | 0.43 |
ENST00000398675.3
|
GXYLT1
|
glucoside xylosyltransferase 1 |
chrX_-_152989798 | 0.43 |
ENST00000441714.1
ENST00000442093.1 ENST00000429550.1 ENST00000345046.6 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr4_-_54930790 | 0.43 |
ENST00000263921.3
|
CHIC2
|
cysteine-rich hydrophobic domain 2 |
chr12_+_100867486 | 0.43 |
ENST00000548884.1
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4 |
chr16_-_31106048 | 0.42 |
ENST00000300851.6
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1 |
chr3_+_58223228 | 0.42 |
ENST00000478253.1
ENST00000295962.4 |
ABHD6
|
abhydrolase domain containing 6 |
chr22_+_50781723 | 0.42 |
ENST00000359139.3
ENST00000395741.3 ENST00000395744.3 |
PPP6R2
|
protein phosphatase 6, regulatory subunit 2 |
chr11_-_64570706 | 0.42 |
ENST00000294066.2
ENST00000377350.3 |
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr17_-_40761375 | 0.42 |
ENST00000543197.1
ENST00000309428.5 |
FAM134C
|
family with sequence similarity 134, member C |
chr10_-_73848531 | 0.42 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr4_-_78740511 | 0.41 |
ENST00000504123.1
ENST00000264903.4 ENST00000515441.1 |
CNOT6L
|
CCR4-NOT transcription complex, subunit 6-like |
chr4_-_141348999 | 0.41 |
ENST00000325617.5
|
CLGN
|
calmegin |
chr4_-_17783135 | 0.41 |
ENST00000265018.3
|
FAM184B
|
family with sequence similarity 184, member B |
chrX_-_48824793 | 0.41 |
ENST00000376477.1
|
KCND1
|
potassium voltage-gated channel, Shal-related subfamily, member 1 |
chr4_+_93225550 | 0.41 |
ENST00000282020.4
|
GRID2
|
glutamate receptor, ionotropic, delta 2 |
chr10_-_15762124 | 0.41 |
ENST00000378076.3
|
ITGA8
|
integrin, alpha 8 |
chr2_-_213403565 | 0.41 |
ENST00000342788.4
ENST00000436443.1 |
ERBB4
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 |
chr19_-_11591848 | 0.41 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
chr11_-_124670550 | 0.41 |
ENST00000239614.4
|
MSANTD2
|
Myb/SANT-like DNA-binding domain containing 2 |
chr7_+_138916231 | 0.41 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr14_-_27066636 | 0.40 |
ENST00000267422.7
ENST00000344429.5 ENST00000574031.1 ENST00000465357.2 ENST00000547619.1 |
NOVA1
|
neuro-oncological ventral antigen 1 |
chr22_-_29075853 | 0.40 |
ENST00000397906.2
|
TTC28
|
tetratricopeptide repeat domain 28 |
chr6_-_11044509 | 0.40 |
ENST00000354666.3
|
ELOVL2
|
ELOVL fatty acid elongase 2 |
chr4_+_55524085 | 0.40 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chrX_+_110339439 | 0.39 |
ENST00000372010.1
ENST00000519681.1 ENST00000372007.5 |
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3 |
chr17_+_56833184 | 0.39 |
ENST00000308249.2
|
PPM1E
|
protein phosphatase, Mg2+/Mn2+ dependent, 1E |
chr1_-_1624083 | 0.39 |
ENST00000378662.1
ENST00000234800.6 |
SLC35E2B
|
solute carrier family 35, member E2B |
chr18_+_67068228 | 0.39 |
ENST00000382713.5
|
DOK6
|
docking protein 6 |
chr5_+_7396141 | 0.39 |
ENST00000338316.4
|
ADCY2
|
adenylate cyclase 2 (brain) |
chr5_+_139493665 | 0.38 |
ENST00000331327.3
|
PURA
|
purine-rich element binding protein A |
chr6_+_41514078 | 0.38 |
ENST00000373063.3
ENST00000373060.1 |
FOXP4
|
forkhead box P4 |
chr12_+_107168342 | 0.38 |
ENST00000392837.4
|
RIC8B
|
RIC8 guanine nucleotide exchange factor B |
chr17_-_1532106 | 0.38 |
ENST00000301335.5
ENST00000382147.4 |
SLC43A2
|
solute carrier family 43 (amino acid system L transporter), member 2 |
chr2_-_180726232 | 0.38 |
ENST00000410066.1
|
ZNF385B
|
zinc finger protein 385B |
chr13_+_32605437 | 0.38 |
ENST00000380250.3
|
FRY
|
furry homolog (Drosophila) |
chr9_-_123476719 | 0.37 |
ENST00000373930.3
|
MEGF9
|
multiple EGF-like-domains 9 |
chr11_-_106889250 | 0.37 |
ENST00000526355.2
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2 |
chr9_-_28670283 | 0.37 |
ENST00000379992.2
|
LINGO2
|
leucine rich repeat and Ig domain containing 2 |
chr12_+_5019061 | 0.37 |
ENST00000382545.3
|
KCNA1
|
potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) |
chr16_-_67450325 | 0.36 |
ENST00000348579.2
|
ZDHHC1
|
zinc finger, DHHC-type containing 1 |
chr5_-_139422654 | 0.36 |
ENST00000289409.4
ENST00000358522.3 ENST00000378238.4 ENST00000289422.7 ENST00000361474.1 ENST00000545385.1 ENST00000394770.1 ENST00000541337.1 |
NRG2
|
neuregulin 2 |
chr3_+_36421826 | 0.36 |
ENST00000273183.3
|
STAC
|
SH3 and cysteine rich domain |
chr8_+_26240414 | 0.35 |
ENST00000380629.2
|
BNIP3L
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like |
chr5_+_56111361 | 0.35 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr12_+_79258547 | 0.35 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr5_+_161274685 | 0.35 |
ENST00000428797.2
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.7 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.4 | 1.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.3 | 1.0 | GO:2000276 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.3 | 1.0 | GO:0097187 | dentinogenesis(GO:0097187) |
0.3 | 0.8 | GO:1900738 | dense core granule biogenesis(GO:0061110) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
0.3 | 2.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.3 | 0.8 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.3 | 2.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.2 | 0.5 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.2 | 1.2 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 1.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.2 | 2.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.6 | GO:1902232 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) regulation of positive thymic T cell selection(GO:1902232) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.2 | 2.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 1.2 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.2 | 1.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.8 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.2 | 1.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 1.6 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.5 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) histone H3-K9 deacetylation(GO:1990619) |
0.2 | 0.8 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 1.0 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 0.2 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.2 | 3.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.5 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.4 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 1.6 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 0.7 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 0.4 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 1.0 | GO:1902231 | positive regulation of keratinocyte apoptotic process(GO:1902174) positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.3 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
0.1 | 1.0 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.4 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.1 | 0.5 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.4 | GO:0038162 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.1 | 0.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.5 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.3 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.1 | 0.9 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 1.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.4 | GO:2000213 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.1 | 1.0 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 0.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.3 | GO:0061114 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.1 | 0.3 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.1 | 0.4 | GO:0050975 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.1 | 0.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.4 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.3 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 0.2 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 1.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.2 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.1 | 0.8 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 0.7 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 0.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.2 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.1 | 0.7 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.6 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.8 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.2 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.4 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.1 | 0.2 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.9 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.7 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.0 | 2.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.0 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.0 | 0.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.4 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.0 | 0.5 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.1 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.0 | 0.1 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
0.0 | 0.3 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.0 | 0.6 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.0 | 0.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.3 | GO:0035624 | receptor transactivation(GO:0035624) |
0.0 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.1 | GO:0060922 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.0 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.2 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.0 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 0.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.0 | 0.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.0 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.0 | 0.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.0 | 0.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.7 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 1.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0090427 | activation of meiosis(GO:0090427) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.1 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.0 | 0.8 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.3 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.5 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.1 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.0 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.2 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.1 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 0.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.0 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.0 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.0 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 1.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.4 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.8 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.1 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.1 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.0 | 0.5 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) substrate-dependent cerebral cortex tangential migration(GO:0021825) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) dorsal root ganglion development(GO:1990791) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 1.8 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 1.0 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.0 | 0.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.0 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.0 | 0.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.1 | GO:0031274 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 2.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 2.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.6 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 1.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.4 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.1 | 0.2 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.2 | GO:0032279 | asymmetric synapse(GO:0032279) symmetric synapse(GO:0032280) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 4.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.0 | 1.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 1.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.2 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.0 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.8 | GO:0043234 | protein complex(GO:0043234) |
0.0 | 1.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 1.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.8 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.5 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 1.3 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 1.3 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.5 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 1.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.0 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.1 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 1.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.3 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.2 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 1.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.5 | 1.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 1.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.4 | 2.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 1.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.3 | 1.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.2 | 1.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.0 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 0.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.2 | 0.5 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.2 | 0.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 2.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.7 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 0.9 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 0.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.7 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.3 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.1 | 0.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.4 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 1.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.4 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.1 | 0.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.4 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 1.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.1 | 0.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 1.5 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.5 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.1 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 1.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.4 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 1.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 1.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 1.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.5 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 1.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 1.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.0 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 1.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.2 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.0 | 0.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.0 | 2.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 1.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 2.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 1.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.4 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 1.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 2.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.0 | 0.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 1.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 2.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 3.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 1.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 2.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 2.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 5.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 1.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 1.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 3.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |